HLS Therapeutics Inc.
HLS
Classement en actions
#21936
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Prix de l'action
$2.94
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$90.88M
Changement (1 jour)
-0.48%
Changement (1 an)
-26.92%
Pays
CA
Échange HLS Therapeutics Inc. (HLS)
Catégorie
Healthcare
Historique du prix de l'action pour HLS Therapeutics Inc. (HLS)
Prix de clôture le plus élevé : $2.76 le 2026-10-01
Prix de clôture le plus bas : $0.42 le 2010-01-01
Prix de clôture le plus bas : $0.42 le 2010-01-01
Historique du prix de l'action de HLS Therapeutics Inc. de 2010 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -6.31% |
| 2025 | 36.44% |
| 2024 | -11.68% |
| 2023 | -61.22% |
| 2022 | -36.61% |
| 2021 | -14.29% |
| 2020 | -5.41% |
| 2019 | 23.57% |
| 2018 | 504.45% |
| 2017 | 5.61% |
| 2016 | -1.13% |
| 2015 | 1.31% |
| 2014 | -15.58% |
| 2013 | 6.18% |
| 2012 | 24.32% |
| 2011 | 122.54% |
| 2010 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $163.40 | 22.20% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.72 | 31.81% |
CH
|
|
| $18.43 | -4.03% |
IN
|
